![]() |
|
|
Molecular Pharmacology, Vol 13, 150-160, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics
1 Division of Clinical Pharmacology, Department of Medicine, and Department of Pharmacology and
Experimental Therapeutics, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
In cultured human skin-derived fibroblast monolayers, steroids which exhibit glucocorticoid and anti-inflammatory activity stimulate the uptake of the amino acid analogue
-aminoisobutyric acid (AIB). Stimulation of AIB uptake is maximal after 5 hr of
exposure to steroid, persists up to 24 hr in the presence of steroid, and is blocked by
cycloheximide. Since the rate of AIB efflux from monolayers is also accelerated in the
presence of steroid, the increase in the rate of AIB uptake is attributable to a greater
stimulation of the rate of AIB influx. In the presence of steroid the apparent Km of
uptake of AIB is reduced without an appreciable effect on the apparent Vmax of uptake.
Steroid analogues lacking an 11
substituent (e.g., prednisone, cortisone) neither
stimulate the uptake of AIB nor block the action of active analogues. The stimulation by
active derivatives is concentration-dependent, and compounds can be ranked in potency
according to their ED50 values for stimulation of AIB uptake: cortisol (44 nM) <
prednisolone (22 nM) < triamcinolone (13 nM) < beclomethasone (7 nM) = betamethasone (7 nM) < dichlorisone (4 nM) < dexamethasone (2 nM). The order of potencies
broadly parallels the relative daily oral replacement doses of these compounds in
humans and indicates a high intrinsic potency of the 21-alcohol chlorinated glucocorticoids, dichlorisone and beclomethasone.
Note:
ACKNOWLEDGMENTS
The author is grateful for the expert technical
assistance of W. H. Shackelford. These studies were
performed in the Alan Bernstein Memorial Laboratories of The Johns Hopkins University School of
Medicine.